American College Of Neuropsychopharmacology Inc
Stable Revenue, Strong Asset Growth, and Low Liabilities for Neuropsychopharmacology Group
EIN: 221736045 · Brentwood, TN · NTEE: G96C · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $8.3M |
| Total Expenses | $3.2M |
| Program Spending | 75% |
| Net Assets | $20.3M |
| Transparency Score | 85/100 |
Search Intent Cockpit
American College Of Neuropsychopharmacology Inc Form 990, Revenue, CEO Pay, and IRS Filing Signals
American College Of Neuropsychopharmacology Inc is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around American College Of Neuropsychopharmacology Inc in one place.
Form 990 Filing Summary
12 filing years are available, with latest revenue of $3.8M and expenses of $3.2M.
Revenue and Expenses
American College Of Neuropsychopharmacology Inc reported $3.8M in revenue and $3.2M in expenses, a surplus of $602K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
85/100 mission score, 0 red flags, and 4 strengths are shown from structured and AI review.
Is American College Of Neuropsychopharmacology Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $2.4M (75%) |
Across stored filings, American College Of Neuropsychopharmacology Inc shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Appears Legitimate | Good filing record; no red flags identified |
| Mission spend | 75% to programs | Excellent |
| Financial durability | Grade A | 12 stored filing years |
| Peer context | Compare with Domino's Franchisee Forum | Tennessee and Category G context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Domino's Franchisee Forum →All Tennessee nonprofits
All Category G
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Brentwood, TN nonprofitsCategory G in Tennessee
Health in Tennessee
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category G spending
Best Category G charities in Tennessee
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Porters Call
Franklin, TN · $1.5M revenue · Score 92/100
Compare side-by-sideSoutheast Community Fire Department Inc
Castalin Spgs, TN · $156K revenue · Score 92/100
Compare side-by-sideSunny Meadows Foundation
Memphis, TN · $670K revenue · Score 90/100
Compare side-by-sidePakistan Association Of Memphis
Cordova, TN · $170K revenue · Score 90/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
American College Of Neuropsychopharmacology Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American College Of Neuropsychopharmacology Inc
American College Of Neuropsychopharmacology Inc (EIN: 221736045) is a nonprofit organization based in Brentwood, TN, classified under NTEE code G96C. The organization reported total revenue of $8.3M and total assets of $25.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American College Of Neuropsychopharmacology Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American College Of Neuropsychopharmacology Inc is a mid-size nonprofit that has been operating for 60 years, with 12 years of IRS 990 filings on record (2012–2023). Revenue has grown at a compound annual rate of 1.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.8M |
| Total Expenses | $3.2M |
| Surplus / Deficit | +$602K |
| Total Assets | $20.8M |
| Total Liabilities | $505K |
| Net Assets | $20.3M |
| Operating Margin | 15.9% |
| Debt-to-Asset Ratio | 2.4% |
| Months of Reserves | 78.3 months |
Financial Health Grade: A
In 2023, American College Of Neuropsychopharmacology Inc reported a surplus of $602K with revenue exceeding expenses, holds 78.3 months of operating reserves (strong position), has a debt-to-asset ratio of 2.4% (very low leverage).
Financial Trends
Over 12 years of filings (2012–2023), American College Of Neuropsychopharmacology Inc's revenue has grown at a compound annual growth rate (CAGR) of 1.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -2.3% | +11.9% | -2.1% |
| 2022 | +27.2% | +100.4% | +8.4% |
| 2021 | -20.1% | -52.2% | +42.5% |
| 2020 | +11.6% | +2.1% | -3.0% |
| 2019 | +3.2% | +2.5% | +4.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1966 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American College Of Neuropsychopharmacology Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, American College Of Neuropsychopharmacology Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $602K, with revenue exceeding expenses.
- Debt-to-asset ratio: 2.4%.
Executive Compensation Analysis
Executive compensation appears reasonable given the organization's size and mission, with no red flags identified in the available filings.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for American College Of Neuropsychopharmacology Inc:
- Consistent revenue generation over multiple years, demonstrating financial stability.
- Significant growth in assets from $11.6M in 2016 to $20.7M in 2023, indicating effective financial management.
- Very low liabilities relative to assets, suggesting strong fiscal responsibility and minimal debt.
- Program expenses consistently represent a substantial portion of total expenses, aligning with mission focus.
Frequently Asked Questions about American College Of Neuropsychopharmacology Inc
Is American College Of Neuropsychopharmacology Inc a legitimate charity?
American College Of Neuropsychopharmacology Inc (EIN: 221736045) is a registered tax-exempt nonprofit based in Tennessee. Our AI analysis gives it a Mission Score of 85/100. It has 12 years of IRS 990 filings on record. Total revenue: $8.3M. No red flags identified. 4 strengths noted. Financial health grade: A.
How does American College Of Neuropsychopharmacology Inc spend its money?
American College Of Neuropsychopharmacology Inc directs 75% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to American College Of Neuropsychopharmacology Inc tax-deductible?
American College Of Neuropsychopharmacology Inc is registered as a tax-exempt nonprofit (EIN: 221736045). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of American College Of Neuropsychopharmacology Inc's spending goes to programs?
American College Of Neuropsychopharmacology Inc directs 75% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does American College Of Neuropsychopharmacology Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), American College Of Neuropsychopharmacology Inc is above average for NTEE category G96C nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is American College Of Neuropsychopharmacology Inc located?
American College Of Neuropsychopharmacology Inc is headquartered in Brentwood, Tennessee and files with the IRS under EIN 221736045. It is classified under NTEE code G96C.
How many years of IRS 990 filings does American College Of Neuropsychopharmacology Inc have?
American College Of Neuropsychopharmacology Inc has 12 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $8.3M in total revenue.
What does American College Of Neuropsychopharmacology Inc do?
American College Of Neuropsychopharmacology Inc is a nonprofit organization in the Diseases, Disorders & Medical Disciplines sector, located in Brentwood, Tennessee. It is classified under NTEE code G96C.
How much revenue does American College Of Neuropsychopharmacology Inc have?
American College Of Neuropsychopharmacology Inc reported total revenue of $8,279,084. Based on 12 IRS 990 filings on record.
What are American College Of Neuropsychopharmacology Inc's total assets?
American College Of Neuropsychopharmacology Inc holds total assets of $25,932,156 as reported in IRS 990 filings.
Where is American College Of Neuropsychopharmacology Inc located?
American College Of Neuropsychopharmacology Inc is based in Brentwood, Tennessee.
What is American College Of Neuropsychopharmacology Inc's EIN?
American College Of Neuropsychopharmacology Inc's Employer Identification Number (EIN) is 221736045. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is American College Of Neuropsychopharmacology Inc?
American College Of Neuropsychopharmacology Inc is classified under NTEE code G96C (Diseases, Disorders & Medical Disciplines).
Is American College Of Neuropsychopharmacology Inc a registered 501(c)(3)?
Yes, American College Of Neuropsychopharmacology Inc is recognized as a tax-exempt organization by the IRS. EIN: 221736045.
Does American College Of Neuropsychopharmacology Inc file IRS Form 990?
Yes, American College Of Neuropsychopharmacology Inc has 12 IRS Form 990 filings on record. The most recent covers tax period 202303.
What was American College Of Neuropsychopharmacology Inc's revenue in 2023?
In the 202303 filing period, American College Of Neuropsychopharmacology Inc reported total revenue of $3,782,275, total expenses of $3,180,068, and net assets of $20,761,567.
Is American College Of Neuropsychopharmacology Inc's revenue growing or declining?
American College Of Neuropsychopharmacology Inc's revenue is relatively stable. Revenue went from $3,872,941 (202203) to $3,782,275 (202303), a -2.3% change. Based on 12 filings on record.
What is American College Of Neuropsychopharmacology Inc's most recent 990 filing?
The most recent IRS Form 990 filing for American College Of Neuropsychopharmacology Inc covers tax period 202303. It shows revenue of $3,782,275, expenses of $3,180,068, total assets of $20,761,567, and liabilities of $504,719.
How much does American College Of Neuropsychopharmacology Inc spend on programs vs administration?
Based on IRS 990 analysis, American College Of Neuropsychopharmacology Inc allocates approximately 75% of expenses to program services, 15% to administrative costs, and 10% to fundraising. This indicates strong program focus.
Is American College Of Neuropsychopharmacology Inc a trustworthy charity?
Based on AI analysis of IRS 990 data, American College Of Neuropsychopharmacology Inc appears trustworthy. Mission Score: 85/100 (Excellent). No red flags identified. 4 strengths noted.
What are American College Of Neuropsychopharmacology Inc's strengths?
Positive indicators for American College Of Neuropsychopharmacology Inc include: Consistent revenue generation over multiple years, demonstrating financial stability.. Significant growth in assets from $11.6M in 2016 to $20.7M in 2023, indicating effective financial management.. Very low liabilities relative to assets, suggesting strong fiscal responsibility and minimal debt.. Program expenses consistently represent a substantial portion of total expenses, aligning with mission focus.. These findings are derived from AI analysis of the organization's financial filings.
How does American College Of Neuropsychopharmacology Inc compensate executives?
Executive compensation appears reasonable given the organization's size and mission, with no red flags identified in the available filings. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
How has the organization managed to achieve such substantial asset growth while maintaining relatively stable revenue?
The organization has consistently generated more revenue than expenses, allowing for the accumulation of assets. For example, in 2023, revenue was $3,782,275 while expenses were $3,180,068, contributing to asset growth.
What specific strategies are in place to ensure that the low liability levels are maintained in future years?
The consistent surplus of revenue over expenses, as seen in the 2023 filing with a surplus of over $600,000, suggests a prudent financial management approach that prioritizes avoiding debt and building reserves.
Filing History
IRS 990 filing history for American College Of Neuropsychopharmacology Inc showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2012–2023), American College Of Neuropsychopharmacology Inc's revenue has grown by 15.5%, moving from $3.3M to $3.8M. Total assets increased by 148.2% over the same period, from $8.4M to $20.8M. Total functional expenses fell by 2.9%, from $3.3M to $3.2M. In its most recent filing year (2023), American College Of Neuropsychopharmacology Inc reported a surplus of $602K, with revenue exceeding expenses. The organization holds $505K in liabilities against $20.8M in assets (debt-to-asset ratio: 2.4%), resulting in net assets of $20.3M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $3.8M | $3.2M | $20.8M | $505K | — | View 990 |
| 2022 | $3.9M | $2.8M | $21.2M | $365K | — | View 990 |
| 2021 | $3.0M | $1.4M | $19.6M | $331K | — | View 990 |
| 2020 | $3.8M | $3.0M | $13.7M | $230K | — | View 990 |
| 2019 | $3.4M | $2.9M | $14.2M | $240K | — | View 990 |
| 2018 | $3.3M | $2.8M | $13.5M | $263K | — | View 990 |
| 2017 | $2.9M | $2.8M | $12.6M | $376K | — | View 990 |
| 2016 | $2.9M | $2.5M | $11.7M | $488K | — | View 990 |
| 2015 | $2.9M | $2.3M | $11.4M | $374K | — | View 990 |
| 2014 | $3.1M | $2.5M | $10.4M | $211K | — | View 990 |
| 2013 | $3.8M | $3.0M | $9.7M | $504K | — | View 990 |
| 2012 | $3.3M | $3.3M | $8.4M | $420K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.8M, expenses of $3.2M, and assets of $20.8M (revenue -2.3% year-over-year).
- 2022: Revenue of $3.9M, expenses of $2.8M, and assets of $21.2M (revenue +27.2% year-over-year).
- 2021: Revenue of $3.0M, expenses of $1.4M, and assets of $19.6M (revenue -20.1% year-over-year).
- 2020: Revenue of $3.8M, expenses of $3.0M, and assets of $13.7M (revenue +11.6% year-over-year).
- 2019: Revenue of $3.4M, expenses of $2.9M, and assets of $14.2M (revenue +3.2% year-over-year).
- 2018: Revenue of $3.3M, expenses of $2.8M, and assets of $13.5M (revenue +14.9% year-over-year).
- 2017: Revenue of $2.9M, expenses of $2.8M, and assets of $12.6M (revenue -0.6% year-over-year).
- 2016: Revenue of $2.9M, expenses of $2.5M, and assets of $11.7M (revenue -0.6% year-over-year).
- 2015: Revenue of $2.9M, expenses of $2.3M, and assets of $11.4M (revenue -7.4% year-over-year).
- 2014: Revenue of $3.1M, expenses of $2.5M, and assets of $10.4M (revenue -18.1% year-over-year).
- 2013: Revenue of $3.8M, expenses of $3.0M, and assets of $9.7M (revenue +17.2% year-over-year).
- 2012: Revenue of $3.3M, expenses of $3.3M, and assets of $8.4M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American College Of Neuropsychopharmacology Inc:
Data Sources and Methodology
This transparency report for American College Of Neuropsychopharmacology Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.